phenotypeId,phenotypeName,referentConceptId,clinicalDescription,literatureReview,phenotypeNotes
436100000,Narcolepsy,436100,"Overview: Unwanted sleep episodes considered refreshing by the patient with or without cataplexy (episodes of muscle weakness brought on by emotions). Sleep paralysis can be present Presentation: Associated after vaccination with the H1N1 vaccination in Sweden (Pandemrix) within 2 weeks of vaccination in 2010-2011. *** Assessment: Sleep studies (polysymnographic testing including the Multiple Sleep Latency Test), CSF evaluation for neuropeptide hypocretin-1 (orexin A) (hyposecretion of this neuropeptide is a diagnostic biomarker for narcolepsy). Plan: Treat reversible causes (sleep apnea, infections), withdraw or do not continue to expose to provoking agent, personal safety including driving safety. Stimulants for daytime sleepiness, REM sleep suppressing drugs for cataplexy. Prognosis: Treatments unfortunately fail to help patients with narcolepsy feel fully alert. Psychosocial support. Weight management. Sleep specialist consult. 2-4 fold increased risk for motor vehicle accdent compared to non-narcoleptics.","",""
